Industry Research Reports
Home > Reports > Medical Devices & Consumables > Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-01-16
Pages: 150 Pages
Report ld: 3474235
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Hemostats Market Size(US$)
CAGR 2025-2031
5.9%
Market Size,2031
USD 4,570
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 3,240 million
Market Forecast in 2031(Value)
US$ 4,570 million
CAGR
5.9%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Hemostats was estimated to be worth US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.
North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.
In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.
This report aims to provide a comprehensive presentation of the global market for Hemostats, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hemostats by region & country, by Type, and by Application.
The Hemostats market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostats.
MARKET SEGMENTATION
By Company
- Ethicon
- Pfizer
- Baxter International Inc.
- C. R. Bard
- The Medicines Company
- Anika Therapeutics
- Advanced Medical Solutions
- Integra LifeSciences Corporation
- B Braun Melsungen AG
- Gelita Medical GmbH
- Equimedical
- Vascular Solutions
- Marine Polymer Technologies
- Z-Medica, LLC
- CryoLife
- BioCer Entwicklungs-GmbH.
- Biom'Up SAS
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Thrombin-Based Hemostats
- Oxidized Regenerated Cellulose Based Hemostats
- Combination Hemostats
- Gelatin Based Hemostats
- Collagen Based Hemostats
Segment by Application
- Prehospital Treatment
- Hospital Treatment
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hemostats manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hemostats in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hemostats in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Hemostats Product Introduction
1.2 Global Hemostats Market Size Forecast
1.2.1 Global Hemostats Sales Value (2020-2031)
1.2.2 Global Hemostats Sales Volume (2020-2031)
1.2.3 Global Hemostats Sales Price (2020-2031)
1.3 Hemostats Market Trends & Drivers
1.3.1 Hemostats Industry Trends
1.3.2 Hemostats Market Drivers & Opportunity
1.3.3 Hemostats Market Challenges
1.3.4 Hemostats Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hemostats Players Revenue Ranking (2024)
2.2 Global Hemostats Revenue by Company (2020-2025)
2.3 Global Hemostats Players Sales Volume Ranking (2024)
2.4 Global Hemostats Sales Volume by Company Players (2020-2025)
2.5 Global Hemostats Average Price by Company (2020-2025)
2.6 Key Manufacturers Hemostats Manufacturing Base and Headquarters
2.7 Key Manufacturers Hemostats Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Hemostats
2.9 Hemostats Market Competitive Analysis
2.9.1 Hemostats Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Hemostats Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostats as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Thrombin-Based Hemostats
3.1.2 Oxidized Regenerated Cellulose Based Hemostats
3.1.3 Combination Hemostats
3.1.4 Gelatin Based Hemostats
3.1.5 Collagen Based Hemostats
3.2 Global Hemostats Sales Value by Type
3.2.1 Global Hemostats Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Hemostats Sales Value, by Type (2020-2031)
3.2.3 Global Hemostats Sales Value, by Type (%) (2020-2031)
3.3 Global Hemostats Sales Volume by Type
3.3.1 Global Hemostats Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Hemostats Sales Volume, by Type (2020-2031)
3.3.3 Global Hemostats Sales Volume, by Type (%) (2020-2031)
3.4 Global Hemostats Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Prehospital Treatment
4.1.2 Hospital Treatment
4.2 Global Hemostats Sales Value by Application
4.2.1 Global Hemostats Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Hemostats Sales Value, by Application (2020-2031)
4.2.3 Global Hemostats Sales Value, by Application (%) (2020-2031)
4.3 Global Hemostats Sales Volume by Application
4.3.1 Global Hemostats Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Hemostats Sales Volume, by Application (2020-2031)
4.3.3 Global Hemostats Sales Volume, by Application (%) (2020-2031)
4.4 Global Hemostats Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Hemostats Sales Value by Region
5.1.1 Global Hemostats Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Hemostats Sales Value by Region (2020-2025)
5.1.3 Global Hemostats Sales Value by Region (2026-2031)
5.1.4 Global Hemostats Sales Value by Region (%), (2020-2031)
5.2 Global Hemostats Sales Volume by Region
5.2.1 Global Hemostats Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Hemostats Sales Volume by Region (2020-2025)
5.2.3 Global Hemostats Sales Volume by Region (2026-2031)
5.2.4 Global Hemostats Sales Volume by Region (%), (2020-2031)
5.3 Global Hemostats Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Hemostats Sales Value, 2020-2031
5.4.2 North America Hemostats Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Hemostats Sales Value, 2020-2031
5.5.2 Europe Hemostats Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Hemostats Sales Value, 2020-2031
5.6.2 Asia Pacific Hemostats Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Hemostats Sales Value, 2020-2031
5.7.2 South America Hemostats Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hemostats Sales Value, 2020-2031
5.8.2 Middle East & Africa Hemostats Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hemostats Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Hemostats Sales Value
6.2.1 Key Countries/Regions Hemostats Sales Value, 2020-2031
6.2.2 Key Countries/Regions Hemostats Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Hemostats Sales Value, 2020-2031
6.3.2 United States Hemostats Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Hemostats Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Hemostats Sales Value, 2020-2031
6.4.2 Europe Hemostats Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Hemostats Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Hemostats Sales Value, 2020-2031
6.5.2 China Hemostats Sales Value by Type (%), 2024 VS 2031
6.5.3 China Hemostats Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Hemostats Sales Value, 2020-2031
6.6.2 Japan Hemostats Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Hemostats Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Hemostats Sales Value, 2020-2031
6.7.2 South Korea Hemostats Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Hemostats Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Hemostats Sales Value, 2020-2031
6.8.2 Southeast Asia Hemostats Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Hemostats Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Hemostats Sales Value, 2020-2031
6.9.2 India Hemostats Sales Value by Type (%), 2024 VS 2031
6.9.3 India Hemostats Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Ethicon
7.1.1 Ethicon Company Information
7.1.2 Ethicon Introduction and Business Overview
7.1.3 Ethicon Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Ethicon Hemostats Product Offerings
7.1.5 Ethicon Recent Development
7.2 Pfizer
7.2.1 Pfizer Company Information
7.2.2 Pfizer Introduction and Business Overview
7.2.3 Pfizer Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Pfizer Hemostats Product Offerings
7.2.5 Pfizer Recent Development
7.3 Baxter International Inc.
7.3.1 Baxter International Inc. Company Information
7.3.2 Baxter International Inc. Introduction and Business Overview
7.3.3 Baxter International Inc. Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Baxter International Inc. Hemostats Product Offerings
7.3.5 Baxter International Inc. Recent Development
7.4 C. R. Bard
7.4.1 C. R. Bard Company Information
7.4.2 C. R. Bard Introduction and Business Overview
7.4.3 C. R. Bard Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 C. R. Bard Hemostats Product Offerings
7.4.5 C. R. Bard Recent Development
7.5 The Medicines Company
7.5.1 The Medicines Company Company Information
7.5.2 The Medicines Company Introduction and Business Overview
7.5.3 The Medicines Company Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 The Medicines Company Hemostats Product Offerings
7.5.5 The Medicines Company Recent Development
7.6 Anika Therapeutics
7.6.1 Anika Therapeutics Company Information
7.6.2 Anika Therapeutics Introduction and Business Overview
7.6.3 Anika Therapeutics Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Anika Therapeutics Hemostats Product Offerings
7.6.5 Anika Therapeutics Recent Development
7.7 Advanced Medical Solutions
7.7.1 Advanced Medical Solutions Company Information
7.7.2 Advanced Medical Solutions Introduction and Business Overview
7.7.3 Advanced Medical Solutions Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Advanced Medical Solutions Hemostats Product Offerings
7.7.5 Advanced Medical Solutions Recent Development
7.8 Integra LifeSciences Corporation
7.8.1 Integra LifeSciences Corporation Company Information
7.8.2 Integra LifeSciences Corporation Introduction and Business Overview
7.8.3 Integra LifeSciences Corporation Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Integra LifeSciences Corporation Hemostats Product Offerings
7.8.5 Integra LifeSciences Corporation Recent Development
7.9 B Braun Melsungen AG
7.9.1 B Braun Melsungen AG Company Information
7.9.2 B Braun Melsungen AG Introduction and Business Overview
7.9.3 B Braun Melsungen AG Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 B Braun Melsungen AG Hemostats Product Offerings
7.9.5 B Braun Melsungen AG Recent Development
7.10 Gelita Medical GmbH
7.10.1 Gelita Medical GmbH Company Information
7.10.2 Gelita Medical GmbH Introduction and Business Overview
7.10.3 Gelita Medical GmbH Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Gelita Medical GmbH Hemostats Product Offerings
7.10.5 Gelita Medical GmbH Recent Development
7.11 Equimedical
7.11.1 Equimedical Company Information
7.11.2 Equimedical Introduction and Business Overview
7.11.3 Equimedical Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Equimedical Hemostats Product Offerings
7.11.5 Equimedical Recent Development
7.12 Vascular Solutions
7.12.1 Vascular Solutions Company Information
7.12.2 Vascular Solutions Introduction and Business Overview
7.12.3 Vascular Solutions Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Vascular Solutions Hemostats Product Offerings
7.12.5 Vascular Solutions Recent Development
7.13 Marine Polymer Technologies
7.13.1 Marine Polymer Technologies Company Information
7.13.2 Marine Polymer Technologies Introduction and Business Overview
7.13.3 Marine Polymer Technologies Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Marine Polymer Technologies Hemostats Product Offerings
7.13.5 Marine Polymer Technologies Recent Development
7.14 Z-Medica, LLC
7.14.1 Z-Medica, LLC Company Information
7.14.2 Z-Medica, LLC Introduction and Business Overview
7.14.3 Z-Medica, LLC Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Z-Medica, LLC Hemostats Product Offerings
7.14.5 Z-Medica, LLC Recent Development
7.15 CryoLife
7.15.1 CryoLife Company Information
7.15.2 CryoLife Introduction and Business Overview
7.15.3 CryoLife Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 CryoLife Hemostats Product Offerings
7.15.5 CryoLife Recent Development
7.16 BioCer Entwicklungs-GmbH.
7.16.1 BioCer Entwicklungs-GmbH. Company Information
7.16.2 BioCer Entwicklungs-GmbH. Introduction and Business Overview
7.16.3 BioCer Entwicklungs-GmbH. Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 BioCer Entwicklungs-GmbH. Hemostats Product Offerings
7.16.5 BioCer Entwicklungs-GmbH. Recent Development
7.17 Biom'Up SAS
7.17.1 Biom'Up SAS Company Information
7.17.2 Biom'Up SAS Introduction and Business Overview
7.17.3 Biom'Up SAS Hemostats Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Biom'Up SAS Hemostats Product Offerings
7.17.5 Biom'Up SAS Recent Development
8 Industry Chain Analysis
8.1 Hemostats Industrial Chain
8.2 Hemostats Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hemostats Sales Model
8.5.2 Sales Channel
8.5.3 Hemostats Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Hemostats Market Trends
Table 2. Hemostats Market Drivers & Opportunity
Table 3. Hemostats Market Challenges
Table 4. Hemostats Market Restraints
Table 5. Global Hemostats Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Hemostats Revenue Market Share by Company (2020-2025)
Table 7. Global Hemostats Sales Volume by Company (2020-2025) & (K Pcs)
Table 8. Global Hemostats Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Hemostats Price by Company (2020-2025) & (USD/Pcs)
Table 10. Key Manufacturers Hemostats Manufacturing Base and Headquarters
Table 11. Key Manufacturers Hemostats Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Hemostats
Table 13. Global Hemostats Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostats as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Hemostats Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Hemostats Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Hemostats Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Hemostats Sales Market Share in Value by Type (2020-2025)
Table 20. Global Hemostats Sales Market Share in Value by Type (2026-2031)
Table 21. Global Hemostats Sales Volume by Type: 2020 VS 2024 VS 2031 (K Pcs)
Table 22. Global Hemostats Sales Volume by Type (2020-2025) & (K Pcs)
Table 23. Global Hemostats Sales Volume by Type (2026-2031) & (K Pcs)
Table 24. Global Hemostats Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Hemostats Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Hemostats Price by Type (2020-2025) & (USD/Pcs)
Table 27. Global Hemostats Price by Type (2026-2031) & (USD/Pcs)
Table 28. Global Hemostats Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Hemostats Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Hemostats Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Hemostats Sales Market Share in Value by Application (2020-2025)
Table 32. Global Hemostats Sales Market Share in Value by Application (2026-2031)
Table 33. Global Hemostats Sales Volume by Application: 2020 VS 2024 VS 2031 (K Pcs)
Table 34. Global Hemostats Sales Volume by Application (2020-2025) & (K Pcs)
Table 35. Global Hemostats Sales Volume by Application (2026-2031) & (K Pcs)
Table 36. Global Hemostats Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Hemostats Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Hemostats Price by Application (2020-2025) & (USD/Pcs)
Table 39. Global Hemostats Price by Application (2026-2031) & (USD/Pcs)
Table 40. Global Hemostats Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Hemostats Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Hemostats Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Hemostats Sales Value by Region (2020-2025) & (%)
Table 44. Global Hemostats Sales Value by Region (2026-2031) & (%)
Table 45. Global Hemostats Sales Volume by Region (K Pcs): 2020 VS 2024 VS 2031
Table 46. Global Hemostats Sales Volume by Region (2020-2025) & (K Pcs)
Table 47. Global Hemostats Sales Volume by Region (2026-2031) & (K Pcs)
Table 48. Global Hemostats Sales Volume by Region (2020-2025) & (%)
Table 49. Global Hemostats Sales Volume by Region (2026-2031) & (%)
Table 50. Global Hemostats Average Price by Region (2020-2025) & (USD/Pcs)
Table 51. Global Hemostats Average Price by Region (2026-2031) & (USD/Pcs)
Table 52. Key Countries/Regions Hemostats Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Hemostats Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Hemostats Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Hemostats Sales Volume, (2020-2025) & (K Pcs)
Table 56. Key Countries/Regions Hemostats Sales Volume, (2026-2031) & (K Pcs)
Table 57. Ethicon Company Information
Table 58. Ethicon Introduction and Business Overview
Table 59. Ethicon Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 60. Ethicon Hemostats Product Offerings
Table 61. Ethicon Recent Development
Table 62. Pfizer Company Information
Table 63. Pfizer Introduction and Business Overview
Table 64. Pfizer Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 65. Pfizer Hemostats Product Offerings
Table 66. Pfizer Recent Development
Table 67. Baxter International Inc. Company Information
Table 68. Baxter International Inc. Introduction and Business Overview
Table 69. Baxter International Inc. Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 70. Baxter International Inc. Hemostats Product Offerings
Table 71. Baxter International Inc. Recent Development
Table 72. C. R. Bard Company Information
Table 73. C. R. Bard Introduction and Business Overview
Table 74. C. R. Bard Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. C. R. Bard Hemostats Product Offerings
Table 76. C. R. Bard Recent Development
Table 77. The Medicines Company Company Information
Table 78. The Medicines Company Introduction and Business Overview
Table 79. The Medicines Company Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. The Medicines Company Hemostats Product Offerings
Table 81. The Medicines Company Recent Development
Table 82. Anika Therapeutics Company Information
Table 83. Anika Therapeutics Introduction and Business Overview
Table 84. Anika Therapeutics Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 85. Anika Therapeutics Hemostats Product Offerings
Table 86. Anika Therapeutics Recent Development
Table 87. Advanced Medical Solutions Company Information
Table 88. Advanced Medical Solutions Introduction and Business Overview
Table 89. Advanced Medical Solutions Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 90. Advanced Medical Solutions Hemostats Product Offerings
Table 91. Advanced Medical Solutions Recent Development
Table 92. Integra LifeSciences Corporation Company Information
Table 93. Integra LifeSciences Corporation Introduction and Business Overview
Table 94. Integra LifeSciences Corporation Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 95. Integra LifeSciences Corporation Hemostats Product Offerings
Table 96. Integra LifeSciences Corporation Recent Development
Table 97. B Braun Melsungen AG Company Information
Table 98. B Braun Melsungen AG Introduction and Business Overview
Table 99. B Braun Melsungen AG Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 100. B Braun Melsungen AG Hemostats Product Offerings
Table 101. B Braun Melsungen AG Recent Development
Table 102. Gelita Medical GmbH Company Information
Table 103. Gelita Medical GmbH Introduction and Business Overview
Table 104. Gelita Medical GmbH Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 105. Gelita Medical GmbH Hemostats Product Offerings
Table 106. Gelita Medical GmbH Recent Development
Table 107. Equimedical Company Information
Table 108. Equimedical Introduction and Business Overview
Table 109. Equimedical Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 110. Equimedical Hemostats Product Offerings
Table 111. Equimedical Recent Development
Table 112. Vascular Solutions Company Information
Table 113. Vascular Solutions Introduction and Business Overview
Table 114. Vascular Solutions Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 115. Vascular Solutions Hemostats Product Offerings
Table 116. Vascular Solutions Recent Development
Table 117. Marine Polymer Technologies Company Information
Table 118. Marine Polymer Technologies Introduction and Business Overview
Table 119. Marine Polymer Technologies Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 120. Marine Polymer Technologies Hemostats Product Offerings
Table 121. Marine Polymer Technologies Recent Development
Table 122. Z-Medica, LLC Company Information
Table 123. Z-Medica, LLC Introduction and Business Overview
Table 124. Z-Medica, LLC Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 125. Z-Medica, LLC Hemostats Product Offerings
Table 126. Z-Medica, LLC Recent Development
Table 127. CryoLife Company Information
Table 128. CryoLife Introduction and Business Overview
Table 129. CryoLife Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 130. CryoLife Hemostats Product Offerings
Table 131. CryoLife Recent Development
Table 132. BioCer Entwicklungs-GmbH. Company Information
Table 133. BioCer Entwicklungs-GmbH. Introduction and Business Overview
Table 134. BioCer Entwicklungs-GmbH. Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 135. BioCer Entwicklungs-GmbH. Hemostats Product Offerings
Table 136. BioCer Entwicklungs-GmbH. Recent Development
Table 137. Biom'Up SAS Company Information
Table 138. Biom'Up SAS Introduction and Business Overview
Table 139. Biom'Up SAS Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 140. Biom'Up SAS Hemostats Product Offerings
Table 141. Biom'Up SAS Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Hemostats Downstream Customers
Table 145. Hemostats Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemostats Product Picture
Figure 2. Global Hemostats Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Hemostats Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Hemostats Sales Volume (2020-2031) & (K Pcs)
Figure 5. Global Hemostats Sales Price (2020-2031) & (USD/Pcs)
Figure 6. Hemostats Report Years Considered
Figure 7. Global Hemostats Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Hemostats Players Sales Volume Ranking (2024) & (K Pcs)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hemostats Revenue in 2024
Figure 10. Hemostats Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Thrombin-Based Hemostats Picture
Figure 12. Oxidized Regenerated Cellulose Based Hemostats Picture
Figure 13. Combination Hemostats Picture
Figure 14. Gelatin Based Hemostats Picture
Figure 15. Collagen Based Hemostats Picture
Figure 16. Global Hemostats Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 17. Global Hemostats Sales Value Market Share by Type, 2024 & 2031
Figure 18. Global Hemostats Sales Volume by Type (2020 VS 2024 VS 2031) & (K Pcs)
Figure 19. Global Hemostats Sales Volume Market Share by Type, 2024 & 2031
Figure 20. Global Hemostats Price by Type (2020-2031) & (USD/Pcs)
Figure 21. Product Picture of Prehospital Treatment
Figure 22. Product Picture of Hospital Treatment
Figure 23. Global Hemostats Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 24. Global Hemostats Sales Value Market Share by Application, 2024 & 2031
Figure 25. Global Hemostats Sales Volume by Application (2020 VS 2024 VS 2031) & (K Pcs)
Figure 26. Global Hemostats Sales Volume Market Share by Application, 2024 & 2031
Figure 27. Global Hemostats Price by Application (2020-2031) & (USD/Pcs)
Figure 28. North America Hemostats Sales Value (2020-2031) & (US$ Million)
Figure 29. North America Hemostats Sales Value by Country (%), 2024 VS 2031
Figure 30. Europe Hemostats Sales Value, (2020-2031) & (US$ Million)
Figure 31. Europe Hemostats Sales Value by Country (%), 2024 VS 2031
Figure 32. Asia Pacific Hemostats Sales Value, (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Hemostats Sales Value by Region (%), 2024 VS 2031
Figure 34. South America Hemostats Sales Value, (2020-2031) & (US$ Million)
Figure 35. South America Hemostats Sales Value by Country (%), 2024 VS 2031
Figure 36. Middle East & Africa Hemostats Sales Value, (2020-2031) & (US$ Million)
Figure 37. Middle East & Africa Hemostats Sales Value by Country (%), 2024 VS 2031
Figure 38. Key Countries/Regions Hemostats Sales Value (%), (2020-2031)
Figure 39. Key Countries/Regions Hemostats Sales Volume (%), (2020-2031)
Figure 40. United States Hemostats Sales Value, (2020-2031) & (US$ Million)
Figure 41. United States Hemostats Sales Value by Type (%), 2024 VS 2031
Figure 42. United States Hemostats Sales Value by Application (%), 2024 VS 2031
Figure 43. Europe Hemostats Sales Value, (2020-2031) & (US$ Million)
Figure 44. Europe Hemostats Sales Value by Type (%), 2024 VS 2031
Figure 45. Europe Hemostats Sales Value by Application (%), 2024 VS 2031
Figure 46. China Hemostats Sales Value, (2020-2031) & (US$ Million)
Figure 47. China Hemostats Sales Value by Type (%), 2024 VS 2031
Figure 48. China Hemostats Sales Value by Application (%), 2024 VS 2031
Figure 49. Japan Hemostats Sales Value, (2020-2031) & (US$ Million)
Figure 50. Japan Hemostats Sales Value by Type (%), 2024 VS 2031
Figure 51. Japan Hemostats Sales Value by Application (%), 2024 VS 2031
Figure 52. South Korea Hemostats Sales Value, (2020-2031) & (US$ Million)
Figure 53. South Korea Hemostats Sales Value by Type (%), 2024 VS 2031
Figure 54. South Korea Hemostats Sales Value by Application (%), 2024 VS 2031
Figure 55. Southeast Asia Hemostats Sales Value, (2020-2031) & (US$ Million)
Figure 56. Southeast Asia Hemostats Sales Value by Type (%), 2024 VS 2031
Figure 57. Southeast Asia Hemostats Sales Value by Application (%), 2024 VS 2031
Figure 58. India Hemostats Sales Value, (2020-2031) & (US$ Million)
Figure 59. India Hemostats Sales Value by Type (%), 2024 VS 2031
Figure 60. India Hemostats Sales Value by Application (%), 2024 VS 2031
Figure 61. Hemostats Industrial Chain
Figure 62. Hemostats Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Hemostats in 2031?
The global market size of Hemostats in 2031 was 4570 Million USD.
What is the annual compound growth rate of the global Hemostats market size from 2025 to 2031?
Which region is expected to have the highest market share?
What was the global market size of Hemostats in 2025?
Which companies rank high in the global Hemostats market?
Related Reports
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hemostats market is projected to grow from US$ 2239 million in 2025 to US$ 3316 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-08
Pages: 175
USD 4900.00
(Single User License)
Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostats market size was US$ 2239 million in 2025 and is forecast to reach a readjusted size of US$ 3316 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published Date: 2026-03-08
Pages: 104
USD 4250.00
(Single User License)
Global Hemostats Market Research Report 2026
The global Hemostats market was valued at US$ 2239 million in 2025 and is anticipated to reach US$ 3316 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 134
USD 2900.00
(Single User License)
Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostats was estimated to be worth US$ 2239 million in 2025 and is projected to reach US$ 3316 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 143
USD 3950.00
(Single User License)
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemostats market is projected to grow from US$ 3076 million in 2024 to US$ 4570 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 173
USD 4900.00
(Single User License)
Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemostats was estimated to be worth US$ 3076 million and is forecast to reach approximately US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 162
USD 5900.00
(Single User License)
Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemostats market size was US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 106
USD 4250.00
(Single User License)
Global Hemostats Market Research Report 2025
The global market for Hemostats was valued at US$ 3076 million in the year 2024 and is projected to reach a revised size of US$ 4570 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-01-16
Pages: 106
USD 2900.00
(Single User License)
Global Hemostats Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published Date: 2024-04-17
Pages: 182
USD 5600.00
(Single User License)
Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published Date: 2024-04-16
Pages: 160
USD 5900.00
(Single User License)
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hemostats market is projected to grow from US$ 2239 million in 2025 to US$ 3316 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-08
Pages: 175
USD 4900.00 (Single User License)Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostats market size was US$ 2239 million in 2025 and is forecast to reach a readjusted size of US$ 3316 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published: 2026-03-08
Pages: 104
USD 4250.00 (Single User License)Global Hemostats Market Research Report 2026
The global Hemostats market was valued at US$ 2239 million in 2025 and is anticipated to reach US$ 3316 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-08
Pages: 134
USD 2900.00 (Single User License)Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostats was estimated to be worth US$ 2239 million in 2025 and is projected to reach US$ 3316 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-08
Pages: 143
USD 3950.00 (Single User License)Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemostats market is projected to grow from US$ 3076 million in 2024 to US$ 4570 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 173
USD 4900.00 (Single User License)Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemostats was estimated to be worth US$ 3076 million and is forecast to reach approximately US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 162
USD 5900.00 (Single User License)Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemostats market size was US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 106
USD 4250.00 (Single User License)Global Hemostats Market Research Report 2025
The global market for Hemostats was valued at US$ 3076 million in the year 2024 and is projected to reach a revised size of US$ 4570 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-01-16
Pages: 106
USD 2900.00 (Single User License)Global Hemostats Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published: 2024-04-17
Pages: 182
USD 5600.00 (Single User License)Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published: 2024-04-16
Pages: 160
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now